Abstract:Osteoarthritis (OA) is the most prevalent degenerative joint disease. The highly regulated balance of matrix synthesis and degradation is disrupted in OA, leading to progressive breakdown of articular cartilage. The molecular events and pathways involved in chondrocyte disfunction of cartilage in OA are not fully understood. It is known that 1,25-dihydroxyvitamin D₃(1,25-(OH)2D3) is synthesized by macrophages derived from synovial fluid of patients with inflammatory arthritis. Vitmain D receptor is expressed in chondrocytes within osteoarthritic cartilage, suggesting a contributory role of 1,25-(OH)2D3 in the aberrant behavior of chondrocytes in OA. However, the physiological function of 1,25-(OH)2D3 on chondrocytes in OA remains obscure. Effect of 1,25-(OH)2D3 on gene expression in chondrocytes was investigated in this study. We found that 1,25-(OH)2D3 activated MMP13 expression in a dose-dependent and time-dependent manner, a major enzyme that targets cartilage for degradation. Interestingly, a specific mitogen-activated protein kinase p38 inhibitor SB203580, but not JNK kinase inhibitor SP600125, abrogated 1,25-(OH)2D3 activation of MMP13 expression. 1,25-(OH)2D3-induced increase in MMP13 protein level was in parallel with the phosphorylation of p38 in chondrocytes. To further address the effect of 1,25-(OH)2D3 on MMP13 expression, transfection assays were used to show that 1,25-(OH)2D3 activated the MMP13 promoter reporter expression. MMP13 is known to target type II collagen and aggrecan for degradation, two major components of cartilage matrix. We observed that the treatment of 1,25-(OH)2D3 in chondrocytes results in downregulation of both type II collagen and aggrecan while MMP13 was upregulated. Taken together, we provide the first evidence to demonstrate that 1,25-(OH)2D3 activates MMP13 expression through p38 pathway in chondrocytes. Since MMP13 plays a major role in cartilage degradation in OA, we speculate that the ability of 1,25-(OH)2D3 to potentiate MMP13 expression might facilitate cartilage erosion at the site of inflammatory arthritis.

1α,25‐Dihydroxyvitamin D<sub>3</sub>Regulates the Expression of Membrane‐Type Matrix Metalloproteinase‐1 in Normal Human Osteoblast‐like Cells

1α,25‐Dihydroxyvitamin D3 Regulates the Expression of Membrane‐Type Matrix Metalloproteinase‐1 in Normal Human Osteoblast‐like Cells

1alpha,25-dihydroxyvitamin D3 regulates the expression of membrane-type matrix metalloproteinase-1 in normal human osteoblast-like cells.

1Α,25-Dihydroxyvitamin D3 Induces the Expression of Membrane-type Matrix Metalloproteinase-1 in Normal Human Osteoblast-like Cells

[The Effects of 1Alpha,25-Dihydroxyvitamin D3 in Regulation Matrix Metalloproteinase and Tissue Metalloproteinase Inhibitors in Human Osteoblasts].

Effect of 1,25-(OH)2 D3 on the expression of amelogenin and ameloblastin secreted by porcine ameloblasts

1 Alpha,25-Dihydroxyvitamin D-3 Inhibits The Differentiation And Bone Resorption By Osteoclasts Generated From Wistar Rat Bone Marrow-Derived Macrophages

1α,25-Dihydroxyvitamin D3 inhibits the differentiation and bone resorption by osteoclasts generated from Wistar rat bone marrow-derived macrophages.

Effect of 1,25(OH)2D3 on the Expression of RANKL and Osteoprotegerin Mrna in Primary Rat Osteoblasts

Stimulation of RANKL and Inhibition of Membrane‐Type Matrix Metalloproteinase‐1 Expression by Parathyroid Hormone in Normal Human Osteoblasts

Effects of 1a,25-Dihydroxyvitamin D3-26,23-Lactone and Its Intermediate Metabolites on Bone Metabolism in vivo and in vitro

[1,25 (OH), Dihydroxyvitamin D3 Induces the Formation of Osteoclasts from Mononuclear Cells of Rat Marrow].

1,25-Dihydroxyvitamin D3 Activates MMP13 Gene Expression in Chondrocytes Through P38 MARK Pathway.

The effect of 1，25-dihydroxyvitamin D3 on matrix Gla protein and Wnt/β-catenin signaling pathways in human osteosarcoma MG63 cells line

[Expression of OPG and RANKL at Protein Level in Human Periodontal Ligament Cells and the Effect of 1alpha,25(oh)(2) Vitamin D(3) on the Secretion of OPG Protein in Vitro].

Adrenocorticotropic Hormone and 1,25-Dihydroxyvitamin D3 Enhance Human Osteogenesis in Vitro by Synergistically Accelerating the Expression of Bone-Specific Genes.

Regulation of membrane-type matrix metalloproteinase-1 expression in human osteoblast-like MG-63 cells by parathyroid hormone

Protein-disulfide Isomerase-associated 3 (Pdia3) Mediates the Membrane Response to 1,25-Dihydroxyvitamin D3 in Osteoblasts

EFFECT OF 1Α,25-Dihydroxyvitamin D3 ON CYTOSKELETON, GAP JUNCTION INTERCELLULAR COMMUNICATION AND [ca2+]i OF OSTEOBLASTS

Effects of 17β-estradiol on the expression of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in human osteoblastic MG-63 cell cultures

Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption